Keywords: shire, pretax, profits, climb, 1st, qtr, pharmaceuticals
Shire's pretax profits climb 40% in 1st qtr
Article | 26 April 2000
Shire Pharmaceuticals Group has reported a 25% rise in revenues for thefirst quarter of 2000 to $119 million, while pretax profits climbed 40% to $26.7 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
